A New Intervention for Implementation of Pharmacogenetics in Psychiatry

Project Information

PSY-PGx

Grant agreement ID: 945151

DOI

10.3030/945151

EC signature date 1 February 2021

Start date 1 March 2021

End date 28 February 2026

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 7 999 611,75

EU contribution

€ 7 999 611,75

Coordinated by

UNIVERSITEIT MAASTRICHT
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Other (2)

Appoint Data Manager

Appoint Data Manager (PGB, M3)

PSY-PGx session at the GAMIAN Convention

PSY-PGx session at the GAMIAN Convention (GAMIAN, M15, M27, M39, M51)

Websites, patent fillings, videos etc. (1)

PSY-PGx website

PSYPGx website LMUM M2

Publications

Peer reviewed articles (3)

A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study

Author(s): Pelgrim TAD, Philipsen A, Young AH, Juruena M, Jimenez E, Vieta E, Jukić M, Van der Eycken E, Heilbronner U, Moldovan R, et al.
Published in: Pharmaceuticals, 2024, ISSN 1424-8247
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ph17020151

Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review.

Author(s): Emma de Brabander, Kristian Kleine Schaars, Therese van Amelsvoort The PSY-PGx Consortium
Published in: Journal of Psychiatric Research, 2024, ISSN 0022-3956
Publisher: Pergamon Press Ltd.
DOI: 10.1016/j.jpsychires.2024.04.001

Pharmacogenomics and the Management of Mood Disorders-A Review

Author(s): Kristian Kleine Schaars and Roos van Westrhenen
Published in: Journal of Personalized Medicine, 2023, ISSN 2075-4426
Publisher: MDPI
DOI: 10.3390/jpm13071183